CACI

Analyst Note: CACI International Inc (CACI)

Date: 2026-06-13 Current Price: $466.42

1. Structural Readiness

State: Context-Only Conservative Entry: — (Awaiting confirmed breakout) Current Price: $466.42 Extension: — Breakout Level: — (Not yet fired) ATR Current: 4.4% (High)

2. Thesis Layer

Primary Secular Thesis: Defense Modernization (C4ISR / Sensors / EW) Directness: High / Direct Beneficiary

CACI is a primary beneficiary of the Defense Modernization thesis, specifically within the C4ISR (Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance), Electronic Warfare (EW), and Counter-Unmanned Aircraft Systems (C-UAS) domains. The company's role is not merely peripheral; it is embedded in mission spaces, with over 1,400 personnel supporting all combatant commands.

Secondary Secular Thesis: Cybersecurity (Security Services / MSSP) Directness: Moderate / Second-Order

The company also participates in the Cybersecurity theme through its specialized expertise in secure enterprise IT environments, DevSecOps, and data analytics. While this is a significant revenue driver, the primary conviction weight rests on the direct, mission-critical nature of its defense modernization work, which is less susceptible to commercial cycle fluctuations.

Combined Exposure: CACI rides two structural waves. The direct exposure to DoD and Intelligence Community (IC) modernization provides a high-confidence floor, while the cybersecurity capabilities offer a growth overlay. The combination suggests a company that is essential to the national security infrastructure, rather than a discretionary vendor.

3. The Business

Business Model & Industry: CACI International Inc operates as a provider of specialized expertise and advanced technology to the U.S. federal government, foreign governments, and commercial enterprises. The company functions primarily as a prime contractor and subcontractor, delivering "Expertise and differentiated Technology" across the intelligence, defense, and federal civilian sectors.

Key Operational Metrics (as of Q1 FY2026):

• Backlog Strength: As of March 31, 2026, the total backlog stood at $33.4 billion, a 6% year-over-year increase. The funded backlog grew even more robustly at 19% year-over-year.
• Book-to-Bill: The company reported a book-to-bill ratio of 0.9x for the quarter, but 1.2x on a trailing twelve-month basis, indicating strong recent award activity relative to revenue recognition.
• Revenue Guidance: Management expects fiscal 2026 revenue to be between $9.5 billion and $9.6 billion, representing total growth of 10.1% to 11.3%. This growth includes approximately 3.5 points from acquisitions, notably $150 million from the ARKA acquisition.
• Margin Outlook: Management is increasing the fiscal 2026 EBITDA margin guidance to the 11.8% to 11.9% range, citing strong execution and portfolio evolution.
• Customer Concentration: Approximately 78% of revenue comes from the DoD and IC, with the remaining 22% split between federal civilian agencies and commercial customers. Domestic operations account for 97% of total revenue.
• Performance Obligations: As of March 31, 2026, remaining performance obligations were $12.3 billion, with management expecting to recognize 45% of this over the next 12 months and 63% over the next 24 months.

Strategic Initiatives: The company is actively expanding its technology portfolio through acquisitions (three completed in FY2025) and organic growth. A key milestone was achieved in the SPECTRAL program, which reached Milestone C, marking the start of low-rate initial production and deployment. Additionally, the "Merlin" system leverages nearly two decades of counter-UAS investments to provide advanced detection and decision-making capabilities.

4. Archetype and Conviction

Archetype: Quality Compounder

CACI fits the Quality Compounder archetype. The evidence points to a company with a durable competitive advantage (deep government relationships, specialized talent), consistent revenue growth (10%+ guidance), and improving profitability (margin expansion to ~11.9%). The company is not a deep value recovery play, nor is it a speculative growth story; it is a mature, execution-driven compounder in a high-barrier-to-entry sector.

Conviction Stack:

• Thesis Strength: High. The alignment with Defense Modernization and C4ISR is direct and critical.
• Evidence Quality: Strong. The backlog of $33.4B and funded backlog growth of 19% provide high visibility into future revenue. The beat on Q1 earnings (EPS beat of 5.4%) reinforces execution capability.
• Structural Quality: High. The book-to-bill of 1.2x (TTM) and the 19% funded backlog growth suggest a healthy pipeline.
• Setup Readiness: Moderate (Forming). The technical setup is not yet confirmed, but the fundamental underpinnings are robust. The "Forming" state suggests the market is digesting the recent earnings beat and guidance raise.
• Rerating Potential: Moderate to High. As the company successfully integrates acquisitions (ARKA) and scales its technology offerings (SPECTRAL, Merlin), the market may re-rate the stock from a pure services multiple to a higher technology/compounder multiple, supported by the margin expansion.

Valuation Context: Forward consensus EPS for FY1 is $28.115 and FY2 is $31.14. At a current price of $466.42, the stock trades at approximately 16.6x FY1 EPS and 15.0x FY2 EPS. This valuation is reasonable for a high-quality compounder in the defense sector, particularly given the 10%+ revenue growth and margin expansion.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Technical Breakout: A confirmed close above the current consolidation range (breakout level) would validate the "Forming" coil and signal institutional accumulation.
• Backlog Growth: Continued growth in the funded backlog above the 19% YoY rate would confirm the strength of the award pipeline.
• Margin Expansion: If the company exceeds the 11.9% EBITDA margin guidance, it would validate the "Quality Compounder" thesis regarding operational leverage.

What Would Invalidate the Case:

• Funding Cuts: A significant reduction in the DoD budget (e.g., below the $838.7B GFY26 level) or a shift in procurement strategy away from C4ISR/EW would threaten the core thesis.
• Execution Failure: A miss on the $9.5B-$9.6B revenue guidance or a failure to integrate acquisitions (ARKA) without margin dilution would damage the compounder narrative.

Gaps in Evidence:

• Acquisition Synergies: While ARKA is mentioned, the specific timeline for full integration and the exact margin contribution beyond the $150M revenue figure is not detailed in the provided evidence.
• International Exposure: The evidence notes 3% of revenue is international, but specific risks or growth drivers in the UK/Europe markets are not quantified in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: High Key evidence: Backlog of $33.4B with 19% funded growth; Revenue guidance of $9.5B-$9.6B (10-11% growth); EBITDA margin expansion to 11.8-11.9%; Direct beneficiary of Defense Modernization and C4ISR/EW themes. Key risks: Technical setup remains "Forming" without confirmed breakout; Heavy reliance on DoD/IC funding (78% of revenue); Integration risks from recent acquisitions; Potential budgetary shifts in GFY26 or beyond. Sizing hint: Position size should reflect the "Forming" technical state; consider scaling in on a confirmed breakout above the consolidation range rather than full entry at current levels. Expected path: Management expects continued revenue growth driven by organic expansion and acquisitions, with margin expansion as the portfolio evolves. The company is positioned to capitalize on the $838.7B DoD budget and specific program milestones like SPECTRAL. Expected horizon: 12 to 24 months, aligned with the recognition of the $12.3B in remaining performance obligations.